Dementia research investment
Biotech founded on charity science raises £48 million to develop next-generation dementia treatments
AstronauTx, working with the UCL DDI, has received funding to develop more treatments for dementia causing diseases like Alzheimer’s
We’re coming towards the end of another busy year here at Alzheimer’s Research UK. While 2016 looks to hold great promise in the search for new ways to improve the lives of people with dementia, we wanted to reflect on the progress we’ve made during 2015.
Late September and early October saw the latest series of autumn party conferences, these are the first party conferences since the general election and, particularly in the case of the Labour Party, see a chance to review current positions and present a new approach for the next five years of parliament.
The world’s largest dementia conference kicked off in Washington D.C. and we’re proud to be representing the work of Alzheimer’s Research UK on this international stage.
This month Emerald Publishing publishes a special issue of the Journal of Public Mental Health entitled “Dementia: a Public Health Priority”.
On 16 and 17 March 2015, the World Health Organization will be hosting their first Ministerial Conference on Global Action Against Dementia.
The Alzheimer’s Research UK Drug Discovery Alliance is a £30m powerhouse of dementia treatment discovery at leading universities for dementia research.
As the UK’s leading dementia research charity, we fund research all over the country; last year we committed £7.6 million to pioneering dementia research.
Drug development takes time, and at Alzheimer’s Research UK we’ve been calling for policy change to help deliver breakthroughs for dementia treatment.